Stock 600267 ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Zhejiang Hisun Pharmaceutical Co., Ltd.

Equities

600267

CNE0000013Z2

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
8.16 CNY +3.29% Intraday chart for Zhejiang Hisun Pharmaceutical Co., Ltd. +9.68% -12.82%
Apr. 29 Zhejiang Hisun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 29 Zhejiang Hisun Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 12,936 11,133 9,705 - -
Enterprise Value (EV) 1 12,936 15,209 13,230 13,283 12,011
P/E ratio 26.2 x -117 x 15.4 x 13.2 x 18.5 x
Yield - - 0.86% 0.98% 2.21%
Capitalization / Revenue - 1.07 x 0.73 x 0.68 x 0.68 x
EV / Revenue - 1.47 x 1 x 0.93 x 0.84 x
EV / EBITDA - 13.5 x 6.83 x 6.63 x 5.49 x
EV / FCF - - - - -
FCF Yield - - - - -
Price to Book - 1.46 x 1.15 x 1.07 x 1.15 x
Nbr of stocks (in thousands) 1,173,876 1,189,385 1,189,385 - -
Reference price 2 11.02 9.360 8.160 8.160 8.160
Announcement Date 3/30/23 4/29/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 - 10,373 13,268 14,242 14,245
EBITDA 1 - 1,129 1,936 2,003 2,189
EBIT 1 - - 1,088 1,264 1,368
Operating Margin - - 8.2% 8.88% 9.6%
Earnings before Tax (EBT) 1 - -82.87 818.5 993.2 690.7
Net income 1 489 -93.17 648 756.8 549.9
Net margin - -0.9% 4.88% 5.31% 3.86%
EPS 2 0.4200 -0.0800 0.5300 0.6200 0.4400
Free Cash Flow - - - - -
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share 2 - - 0.0700 0.0800 0.1800
Announcement Date 3/30/23 4/29/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales - - - - - - - - - -
EBITDA - - - - - - - - - -
EBIT - - - - - - - - - -
Operating Margin - - - - - - - - - -
Earnings before Tax (EBT) - - - - - - - - - -
Net income 232.3 - - - - - - - - -
Net margin - - - - - - - - - -
EPS 1 0.1900 0.1800 0.0600 -0.4700 0.2100 -0.0400 0.0400 0.2900 0.1100 -0.0700
Dividend per Share - - - - - - - - - -
Announcement Date 4/19/23 8/4/23 10/27/23 4/29/24 4/30/24 - - - - -
1CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt 1 - 4,076 3,525 3,578 2,306
Net Cash position 1 - - - - -
Leverage (Debt/EBITDA) - 3.612 x 1.821 x 1.786 x 1.053 x
Free Cash Flow - - - - -
ROE (net income / shareholders' equity) - -1.15% 7.43% 8.03% 6.35%
ROA (Net income/ Total Assets) - - 4.4% 4.9% -
Assets 1 - - 14,728 15,445 -
Book Value Per Share 2 - 6.430 7.090 7.630 7.070
Cash Flow per Share 2 - 1.240 0.8500 1.740 -
Capex - - - - -
Capex / Sales - - - - -
Announcement Date 3/30/23 4/29/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Zhejiang Hisun Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
8.16 CNY
Average target price
7.4 CNY
Spread / Average Target
-9.31%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. Stock Zhejiang Hisun Pharmaceutical Co., Ltd.
-12.82% 1.34B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+33.84% 704B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+28.59% 577B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.23% 348B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.12% 327B
ABBVIE INC. Stock AbbVie Inc.
+4.79% 288B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.81% 234B
NOVARTIS AG Stock Novartis AG
+4.93% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-9.78% 194B
AMGEN INC. Stock Amgen Inc.
-3.05% 147B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600267 Stock
  4. Financials Zhejiang Hisun Pharmaceutical Co., Ltd.